Trial Profile
Combination High Dose Melphalan and Autologous PBSC Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2011 Actual initiation date changed from Aug 2008 to May 2005 as reported by ClinicalTrials.gov.
- 10 Jan 2011 Actual end date changed from Jul 2009 to Jul 2011 as reported by ClinicalTrials.gov.
- 10 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.